Avatar

contact@evitria.com

Share this article:

Join our newsletter to stay up-to-date with the latest insights in biotechnology!

Name
Data protection

What is a CRO?

Avatar

If you’re in the pharmaceutical or biotech industry, you’ve probably heard the term “CRO” thrown around quite a bit. But what exactly is a CRO, and what do they do?

In this article, we’ll take a deep dive into the world of CROs, exploring what they are, what services they offer, how they can benefit your research endeavors and where evitria comes in with dedicated antibody expression services.

A definition of CRO

A Contract Research Organization (CRO) is a company that provides research services to pharmaceutical, biotech, and medical device companies, as well as government agencies, foundations, and academic institutions.

CROs offer a variety of services, including preclinical research, clinical trial management, data management, biostatistics, and regulatory affairs (issued by regulatory authorities like the FDA).

As such, CROs can be effective partners for the pharmaceutical industry, facilitating project management in the biotechnology, healthcare and pharma sector as well as in other fields in life sciences.

The history of CROs

CROs first emerged in the 1970s, when pharmaceutical companies began outsourcing some of their research functions to external organizations. The rise of CROs was driven by a need for cost savings, as well as a desire for greater expertise and flexibility in research operations.

Over the years, CROs have become increasingly specialized, offering a wide range of services to support the drug development process – from drug discovery, product development, clinical development and clinical trial processes (good clinical practice- respectively GCP compliant) to commercialization and quality assurance.

Types of CROs

There are several types of CROs, each with its own strengths and areas of focus. The three main types of CROs are:

Full-service CROs

Full-service CROs offer a comprehensive suite of services to support the entire drug development process. They have expertise in preclinical and clinical research, clinical trial management, data management, biostatistics, and regulatory affairs, and can handle all aspects of a drug development program.

Functional service providers (FSPs)

Functional service providers (FSPs) are specialized CROs that offer specific services, such as data management or clinical monitoring. FSPs typically work on a project-by-project basis and are often brought in to provide additional support to a full-service CRO.

Specialty CROs

Specialty CROs offer highly specialized services in specific areas, such as oncology or rare diseases. These CROs have deep expertise in their area of focus and can provide valuable support to drug development programs that require specialized knowledge.

Read more: The role of CROs in monoclonal antibody production

Services offered by CROs

CROs offer a wide range of services to support drug development programs. Some of the key services offered by CROs include:

Preclinical services

CROs, also referred to as Clinical Research Organizations, can provide a variety of preclinical research services, including in vitro and in vivo testing, toxicology studies, and pharmacokinetic and pharmacodynamic (PK/PD) assessments. These services are designed to help drug developers evaluate the safety and efficacy of their compounds before they move into clinical trials.

Clinical trial management

CROs can manage all aspects of clinical trials, from study protocol development to study design, site selection, patient recruitment, and monitoring. CROs are often able to accelerate the timeline of clinical studies by leveraging their experience and expertise in study management.

Data management and biostatistics

CROs can provide data management and biostatistics services, including database design and development, data entry and cleaning, and statistical analysis. These services help ensure that trial data is accurate, complete, and compliant with regulatory requirements.

Regulatory affairs

CROs can provide support for regulatory affairs, including preparation of regulatory submissions, interaction with regulatory agencies, and compliance with regulations and guidelines. This can be particularly valuable for small or mid-sized companies that may not have the internal resources to manage regulatory affairs on their own.

Advantages of working with a CRO

There are several advantages to working with a CRO for drug development programs. Some of the key benefits include:

  • Cost savings: Outsourcing research functions to a CRO can be more cost-effective than conducting the research in-house, particularly for start-ups as well as for small or mid-sized companies that may not have the resources to manage all aspects of drug development.
  • Expertise and experience: CROs have deep expertise and experience in all aspects of drug development, including preclinical research, clinical trial management, and regulatory affairs. This can be particularly valuable for companies that are new to drug development or are working on complex programs.
  • Flexibility and scalability: Working with a CRO can provide greater flexibility and scalability than conducting research in-house. CROs can quickly ramp up or down their services to meet changing project needs, and can provide additional support as needed.

A specialized CRO like evitria accelerates early-stage programs through its High-Throughput Antibody Production Service, enabling biotechs to screen large antibody panels in CHO without building in-house expression infrastructure.

Choosing the right CRO for your project

Choosing the right CRO for your project can be challenging, as there are many factors to consider – be it a CRO for recombinant antibody production or any area.

Some key considerations include:

  • Area of expertise: Different CROs have different areas of expertise, so it’s important to choose a CRO that has experience and expertise in the specific area you need support in.
  • Track record: It’s important to choose a CRO with a strong track record of success in drug development. Look for CROs that have experience in similar projects and have a proven track record of delivering high-quality results.
  • Communication and collaboration: Choose a CRO that communicates clearly and collaborates effectively with your team. Look for CROs that are responsive to your needs and are willing to work closely with you to achieve your goals.

Common challenges and pitfalls of working with CROs

While working with a CRO can provide many benefits, there are also some common challenges and pitfalls to be aware of. Some of these include:

Communication and coordination

Effective communication and coordination can be challenging when working with a CRO, particularly if the CRO is located in a different geographic region or time zone. It’s important to establish clear lines of communication and to proactively address any issues that arise.

Quality control

Ensuring quality control can be challenging when working with a CRO, particularly if the CRO is located in a different region or has different quality standards. It’s important to establish clear quality control measures and to monitor the CRO’s performance closely.

Conclusion – What is a CRO?

In conclusion, CROs are valuable partners for pharmaceutical, biotech, and medical device companies looking to accelerate the drug development process. By outsourcing research functions to a CRO, companies can benefit from cost savings, expertise and experience, and flexibility and scalability.

When choosing a CRO, it’s important to consider the CRO’s area of expertise, track record, and communication and collaboration skills, as well as to be aware of common challenges and pitfalls, also related to distinctive therapeutic areas.

In summary, a contract research organization (CRO) is a company that provides research services to pharmaceutical, biotech, and medical device companies. CROs can provide a range of services, including preclinical research, clinical trial management, data management and biostatistics, and regulatory affairs. Working with a CRO can provide cost savings, expertise and experience, and flexibility and scalability.

When choosing a CRO, it’s important to consider the CRO’s area of expertise, track record, and communication and collaboration skills.

FAQs – What is a CRO?

CRO stands for Contract Research Organization.

CROs provide a range of services for drug development programs, including preclinical research, clinical trial management, data management and biostatistics, and regulatory affairs.

Outsourcing research functions to a CRO can be more cost-effective than conducting the research in-house, particularly for small or mid-sized companies that may not have the resources to manage all aspects of drug development.

Some key considerations when choosing a CRO include the CRO’s area of expertise, track record, and communication and collaboration skills.

Some common challenges when working with a CRO include communication and coordination issues, and ensuring quality control measures are in place.

Share this article:

Join our newsletter to stay up-to-date with the latest insights in biotechnology!

Name
Data protection
Avatar

Written by Team evitria Follow on linkedin

Read more from Team evitria

Further readings about Antibodies Journal

  • AAX Biotech and evitria to expand access to Opti-mAb® technology in early antibody development 

    STOCKHOLM / 23 April 2026 – Biotech company AAX Biotech, a leading innovator in technologies for antibody-based therapies, today announced a partnership with evitria AG, an expert provider of antibody engineering and expression services, to enable the use of its Opti-mAb® technology in early antibody development workflows.  AAX Biotech develops proprietary technologies, including Opti-mAb®, supporting […]

    Avatar
  • Polyclonal Antibody Production: A Comprehensive Guide

    This article will provide a comprehensive guide to polyclonal antibody production (pAb production), outlining the steps involved in the process, discussing the advantages and disadvantages of using polyclonal antibodies, and exploring the alternatives to polyclonal antibody production, including recombinant antibody production.

    Avatar
  • Differences between monoclonal antibodies and recombinant monoclonal antibodies

    There are some major differences between monoclonal and recombinant monoclonal antibodies – discover the most important ones in this article!

    Avatar
  • Bengt Thorsson and Johan Rockberg to join Atlas Antibodies’ Board of Directors

    We are pleased to announce the election of Bengt Thorsson and Johan Rockberg to Atlas Antibodies’ Board of Directors, following the AGM on May 23, 2025. Åsa Riisberg has been re-elected as Chair of the Board and Catarina Flyborg, Gavin Wood, Christian Eberle and Louise Kores have been re-elected as board members. We thank Mathias […]

    Avatar
  • Press release: evitria Celebrates 15 Years with Exclusive Giveaway for Industry Experts

    Tickets for Festival of Biologics, Networking Dinner, and Exclusive Tour of evitria AG in Zürich Up for Grabs Zurich, Switzerland – March 2025 – evitria, a leading provider of antibody development services, is celebrating its 15th anniversary with an exciting giveaway that offers an exclusive opportunity to attend the Festival of Biologics in Basel, Switzerland. […]

    Avatar
  • Engineering bispecific antibodies

    Recorded Presentation: From mAb to bAb Developing drugs requires navigating complex technical, practical, and strategic challenges quickly. Optimizing a drug’s activity and effectiveness and subsequently considering the IP landscape are crucially important balancing acts. Here, we demonstrate how evitria’s extensive expertise in antibody production can help you engineer, reformat, and produce your therapeutic, using a […]

    Avatar